CZP durability was comparable with durability data on other bDMARDs in RA patients. Patient characteristics that were associated with greater durability included younger age, TNFi-naïvety, and disease duration ≥ 1 year. Findings may be helpful in informing clinicians on a patient's likelihood of discontinuing CZP, based on their baseline characteristics.
Keyphrases
- clinical trial
- end stage renal disease
- case report
- electronic health record
- newly diagnosed
- ejection fraction
- chronic kidney disease
- rheumatoid arthritis
- big data
- prognostic factors
- palliative care
- peritoneal dialysis
- study protocol
- systemic lupus erythematosus
- disease activity
- deep learning
- data analysis
- machine learning
- patient reported outcomes
- phase iii
- ankylosing spondylitis